Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Embecta Corp. and certain officers, alleging violations of federal securities laws. The suit covers investors who purchased Embecta securities between November 25, 2025 and May 4, 2026. The complaint claims defendants made false and misleading statements about the company's business, including touting its pen needle business as "incredibly resolute" shortly before missing expectations and cutting fiscal 2026 guidance. On May 5, 2026, Embecta reported second quarter fiscal 2026 results showing revenue declined over 14%, far worse than the prior guidance of flat to a 2% decline, and lowered its full-year outlook, partly due to weakness in pen needle sales. Investors have until August 17, 2026 to seek lead plaintiff appointment.
Embecta CorpClass action lawsuit alleging securities fraud for false statements about pen needle business and guidance.